Supplements & Healthspan · Updated September 2026
AREDS2 is one of the few supplement formulations with large randomised trial evidence behind it. It is also one of the most widely misapplied, because it was tested in a specific population and does not prevent macular degeneration in people who do not have it.
The Age-Related Eye Disease Study and its successor AREDS2 are large randomised trials conducted by the US National Eye Institute, and they are the reason this supplement category has any serious standing at all.
The original AREDS formulation combined vitamin C, vitamin E, beta-carotene, zinc and copper, and reported reduced risk of progression to advanced age-related macular degeneration in participants who already had intermediate AMD or advanced AMD in one eye. AREDS2 refined the formula: beta-carotene was replaced with lutein and zeaxanthin after the earlier trial found increased lung cancer risk associated with beta-carotene in smokers and former smokers, and a lower-zinc variant was tested.
The trials enrolled people with existing intermediate or advanced AMD. The benefit demonstrated was slowing progression toward advanced disease in that population.
The trials did not show that these formulations prevent AMD in people with healthy eyes or with only early changes. Marketing that presents an AREDS2 formula as general eye health maintenance is extending the evidence beyond what it supports, and the zinc doses involved are high enough that indiscriminate long-term use is not a neutral choice.
Lutein and zeaxanthin are carotenoids concentrated in the macula, where they form macular pigment and filter blue light. Beyond their role in AREDS2, there is research on macular pigment optical density and some work on visual performance measures such as glare recovery. They are also abundant in leafy greens and egg yolks, which is the cheaper route.
Omega-3 fatty acids were tested in AREDS2 as an addition to the formulation and did not produce additional benefit for AMD progression. There is separate evidence for omega-3 in dry eye disease, though trial results there have been mixed.
Vitamin A and lifestyle factors. The single largest modifiable risk factor for AMD is smoking, and stopping does more than any supplement. Blood pressure control, cardiovascular risk management and UV eye protection all have supporting rationale.
| Formulation | Evidence | Appropriate for | Note |
|---|---|---|---|
| AREDS2 formula | Large RCT | Intermediate or advanced AMD | Discuss with an ophthalmologist |
| Lutein / zeaxanthin alone | Moderate | General macular pigment support | Also available from diet |
| Original AREDS with beta-carotene | RCT, superseded | Non-smokers only | Avoid entirely if you smoke or have smoked |
| Bilberry, astaxanthin blends | Weak | — | Marketing-led |
| Omega-3 for AMD | Not supported by AREDS2 | — | Separate evidence for dry eye |
| Dietary greens and eggs | Good | Everyone | The cheapest source |
The AREDS formulations contain zinc at doses well above typical dietary intake, and that is a deliberate part of the tested formula rather than an incidental inclusion. High-dose zinc taken long term can interfere with copper absorption, which is precisely why copper is included in the formulation — a detail that gets dropped from some copycat products.
This is a good illustration of why the specific formulation matters. A product marketed as 'AREDS2-style' that omits copper, uses different doses, or adds a proprietary blend is not the thing that was tested, and the trial evidence does not transfer to it. Check that the label matches the AREDS2 composition rather than gesturing at it.
This is general information, not medical advice. AREDS2 supplementation is a decision to make with an ophthalmologist or optometrist who has examined your eyes and knows your AMD stage. Sudden vision changes, distortion of straight lines, a new blind spot, flashes, floaters or vision loss require urgent assessment — these can indicate retinal detachment or wet AMD, where treatment timing materially affects the outcome. Do not use beta-carotene-containing formulations if you smoke or have smoked.
Ingredient list and doses matching the actual AREDS2 composition, including copper alongside zinc, rather than an 'inspired by' blend.
Beta-carotene replaced by lutein and zeaxanthin, per AREDS2 — particularly important for anyone who has ever smoked.
Independent verification of content, since carotenoid potency degrades and label accuracy in this category varies.
Bought on the advice of an eye care professional who knows your AMD stage, rather than as general eye maintenance.
Ranked by evidence strength for the specific population each suits. The first entry is only appropriate for a defined group, which is the most important point on this page.
The formulation with genuine randomised trial evidence for slowing progression to advanced AMD — in people who already have intermediate or advanced disease. Check that the label matches the actual AREDS2 composition including copper, and that it contains no beta-carotene.
View on AmazonThe carotenoids that form macular pigment, with research on macular pigment density and some visual performance measures. A reasonable option for general macular support, with the honest caveat that leafy greens and egg yolks supply them at lower cost.
View on AmazonUV exposure contributes to cataract risk and to damage of the thin periorbital skin. The specification to check is UV400 or 100% UV protection — lens darkness is unrelated to it, and dark lenses without UV filtering dilate the pupil and let more UV in.
View on AmazonPreservative-free formulations avoid the irritation that preservatives cause with frequent use, which matters because dry eye is typically managed with repeated daily application. Persistent dry eye warrants an assessment rather than indefinite self-treatment.
View on AmazonA simple grid used to monitor central vision for distortion, which can be an early sign of wet AMD where treatment timing materially affects outcomes. Costs almost nothing and is the highest-value item here for anyone with AMD risk factors.
View on AmazonNo — and this is the most consequential misunderstanding in the category. The AREDS and AREDS2 trials enrolled people who already had intermediate age-related macular degeneration or advanced AMD in one eye, and demonstrated reduced risk of progression to advanced disease in that population. They did not show prevention in people with healthy eyes, and the high zinc doses involved make indiscriminate long-term use a decision rather than a neutral default.
Because the original AREDS trial and other research found increased lung cancer risk associated with beta-carotene supplementation in smokers and former smokers. AREDS2 replaced it with lutein and zeaxanthin, which performed comparably without that risk. Anyone who smokes or has ever smoked should avoid beta-carotene-containing eye formulations entirely.
They are the carotenoids that form macular pigment in the retina, and there is research on macular pigment optical density and some visual performance measures such as glare recovery. As part of the AREDS2 formula in people with intermediate or advanced AMD, the evidence is stronger. As general supplementation, they are reasonable but also abundant in leafy greens and egg yolks at considerably lower cost.
AREDS2 tested the addition of omega-3 fatty acids to the formulation and found no additional benefit for AMD progression. There is a separate body of research on omega-3 for dry eye disease, where trial results have been mixed. Omega-3 has other established cardiovascular relevance, but AMD progression is not a supported indication.
Stop smoking if you smoke — it is the largest modifiable risk factor for age-related macular degeneration and for cataract. Beyond that: regular eye examinations that can detect changes before you notice symptoms, UV protection outdoors, blood pressure and cardiovascular risk management, and a diet with plenty of leafy greens. Any sudden vision change, distortion of straight lines or new blind spot needs urgent assessment.
Take the 7-question quiz to get your personalized supplement and lifestyle stack — tailored to your age, fitness level, and longevity concerns.
Take the QuizA 28-day fillable sleep log built around the seven levers that actually move sleep, so you test one per week and see what it did.